Skip to content
  • Instagram
  • X
Rareatives

Rareatives

    • About
    • Blog
    • Contact
    • Resources
    • World Orphan Drug Congress

MELAS

  • Tisento Therapeutics’ Chad Glasser Discusses PRIZM Trial, Zagociguat Development for MELAS
    April 29, 2026

    Tisento Therapeutics’ Chad Glasser Discusses PRIZM Trial, Zagociguat Development for MELAS

    Jessica Lynn
  • Tisento Therapeutics’ Patient-Informed Phase 2 Trial is Advancing MELAS Research
    February 26, 2025

    Tisento Therapeutics’ Patient-Informed Phase 2 Trial is Advancing MELAS Research

    Jessica Lynn

Rareatives is a patient-led publication where the unique stories of the rare disease community become headline news. We’re flipping the script on rare diseases. Not just awareness — action. Your story could spark the next big change. Ready to rewrite the narrative?

Subscribe and get the latest news to your mailbox.

  • Instagram
  • Twitter
    • About
    • Blog
    • Contact
    • Resources
    • World Orphan Drug Congress

Loading Comments...